MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ALXO ALX Oncology
- 1.620
- +0.140+9.46%
Close Dec 20 16:00 ET
- 1.620
- -0.001-0.03%
Post 20:01 ET
85.44MMarket Cap-0.55P/E (TTM)
1.670High1.510Low2.17MVolume1.510Open1.480Pre Close3.48MTurnover6.16%Turnover RatioLossP/E (Static)52.74MShares17.82552wk High0.62P/B56.91MFloat Cap1.19052wk Low--Dividend TTM35.13MShs Float117.450Historical High--Div YieldTTM10.81%Amplitude1.190Historical Low1.606Avg Price1Lot Size
About ALX Oncology Company
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolALXO
Company NameALX Oncology
Listing DateJul 17, 2020
Issue Price19.00
Founded2015
CEOMr. Jason Lettmann
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address323 Allerton Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-466-7125
Websitehttp://www.alxoncology.com
Company Executives
- Name
- Position
- Salary
- Jason Lettmann
- Chief Executive Officer and Director
- 4.86M
- Dr. Alan B. Sandler, M.D.
- Chief Medical Officer
- --
- Shelly Pinto
- Senior Vice President, Finance, Interim Chief Financial Officer and Chief Accounting Officer
- --
- Dr. Jaume Pons, PhD
- President and Chief Scientific Officer
- 2.75M
- Dr. Corey S. Goodman,PhD
- Executive Chairman of the Board
- 206.61K
- Scott Garland
- Independent Director
- 105.66K
- Rekha Hemrajani, M.B.A.
- Independent Director
- 181.02K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.